Search Results - "Verschueren, Patrick"

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis by Doumen, Michaël, De Cock, Diederik, Pazmino, Sofia, Bertrand, Delphine, Joly, Johan, Westhovens, René, Verschueren, Patrick

“…Self-efficacy, or patients' confidence in their ability to control disease and its consequences, was recently prioritised in EULAR recommendations for…”
Get full text

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis by Sepriano, Alexandre, Kerschbaumer, Andreas, Bergstra, Sytske Anne, Smolen, Josef S, van der Heijde, Désirée, Caporali, Roberto, Edwards, Christopher J, Verschueren, Patrick, de Souza, Savia, Pope, Janet, Takeuchi, Tsutomu, Hyrich, Kimme, Winthrop, Kevin L, Aletaha, Daniel, Stamm, Tanja, Schoones, Jan W, Landewé, Robert B M

“…To perform a systematic literature review (SLR) concerning the safety of synthetic(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to…”
Get more information

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis by Kerschbaumer, Andreas, Sepriano, Alexandre, Bergstra, Sytske Anne, Smolen, Josef S, van der Heijde, Désirée, Caporali, Roberto, Edwards, Christopher John, Verschueren, Patrick, de Souza, Savia, Pope, Janet E, Takeuchi, Tsutomu, Hyrich, Kimme L, Winthrop, Kevin L, Aletaha, Daniel, Stamm, Tanja A, Schoones, Jan W, Landewé, Robert B M

“…To update the evidence on efficacy of DMARDs (disease-modifying antirheumatic drugs) and inform the taskforce of the 2022 update of the European Alliance of…”
Get more information

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response by Doumen, Michaël, Pazmino, Sofia, Bertrand, Delphine, De Cock, Diederik, Joly, Johan, Westhovens, René, Verschueren, Patrick

“…Fatigue is common in rheumatoid arthritis (RA). We aimed to explore its longitudinal course, predictors and association with disease activity in early RA. Data…”
Get more information

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis by Bergstra, Sytske Anne, Sepriano, Alexandre, Kerschbaumer, Andreas, van der Heijde, Désirée, Caporali, Roberto, Edwards, Christopher John, Verschueren, Patrick, de Souza, Savia, Pope, Janet E, Takeuchi, Tsutomu, Hyrich, Kimme L, Winthrop, Kevin L, Aletaha, Daniel, Stamm, Tanja A, Schoones, Jan W, Smolen, Josef S, Landewé, Robert B M

“…This systematic literature review (SLR) regarding the efficacy, duration of use and safety of glucocorticoids (GCs), was performed to inform the 2022 update of…”
Get more information

Unraveling Patient‐Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study by van der Elst, Kristien, Meyfroidt, Sabrina, De Cock, Diederik, De Groef, An, Binnard, Els, Moons, Philip, Verschueren, Patrick, Westhovens, René

“…Objective To unravel the perspective of patients with rheumatoid arthritis (RA) on preferred health and treatment outcomes at 2 time points during the early…”
Get full text

Technical and Diagnostic Performance of 6 Assays for the Measurement of Citrullinated Protein/Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis by Coenen, Dries, Verschueren, Patrick, Westhovens, Rene, Bossuyt, Xavier

“…Several anticitrullinated protein/peptide antibodies (ACPA) assays have been reported to be of diagnostic value for rheumatoid arthritis (RA). We evaluated the…”
Get full text

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis by Doumen, Michaël, De Cock, Diederik, Pazmino, Sofia, Bertrand, Delphine, Joly, Johan, Westhovens, René, Verschueren, Patrick

“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups by Doumen, Michael, Westhovens, Rene, Pazmino, Sofia, Bertrand, Delphine, Stouten, Veerle, Neys, Claudia, Creten, Nelly, Van Laeken, Els, Verschueren, Patrick, De Cock, Diederik

“…Abstract Background Shifts in treatment strategies for rheumatoid arthritis (RA) have made ambulatory care more labour-intensive. These developments have…”
Get full text

Patient‐Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target by Van der Elst, Kristien, Verschueren, Patrick, Stouten, Veerle, Pazmino, Sofia, De Groef, An, De Cock, Diederik, Joly, Johan, Moons, Philip, Westhovens, René

“…Objective Treating early, intensively, and to target leads to rapid disease control, preventing joint damage and loss of function in early rheumatoid arthritis…”
Get full text

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA by Stouten, Veerle, Westhovens, René, Pazmino, Sofia, De Cock, Diederik, Van der Elst, Kristien, Joly, Johan, Verschueren, Patrick

“…Abstract Objectives To investigate whether MTX should be combined with an additional DMARD and bridging glucocorticoids as initial treatment for patients with…”
Get full text

Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression by Pathak, Janak L., Bakker, Astrid D., Luyten, Frank P., Verschueren, Patrick, Lems, Willem F., Klein-Nulend, Jenneke, Bravenboer, Nathalie

“…Bone remodeling can be disturbed in active rheumatoid arthritis (RA), possibly as a result of elevated levels of circulating inflammatory cytokines…”
Get full text

Treat-to-target fixed dose rituximab retreatment versus fixed interval retreatment with disease activity-guided rituximab dose optimisation for patients with rheumatoid arthritis: study protocol for a multicentre randomised controlled superiority trial focusing on long-term disease impact (RITUXERA) by De Meyst, Elias, Bertrand, Delphine, Joly, Johan, Doumen, Michaël, Marchal, Anja, Thelissen, Marc, Neerinckx, Barbara, Westhovens, René, Verschueren, Patrick

“…The optimal retreatment strategy with rituximab for rheumatoid arthritis (RA) remains a point of discussion. Depending on local guidelines, rituximab can…”
Get full text

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study by Geldof, Jeroen, Truyens, Marie, Sabino, João, Ferrante, Marc, Lambert, Jo, Lapeere, Hilde, Hillary, Tom, Van Laethem, An, de Vlam, Kurt, Verschueren, Patrick, Padalko, Elizaveta, Lobaton, Triana, Vermeire, Séverine

“…The risks and impact of COVID19 disease and vaccination in patients with Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID…”
Get full text

JAK inhibition and the holy grail for pain control in early RA by Pazmino, Sofia, Verschueren, Patrick, Westhovens, René

“…[...]there might also be a specific mechanism of action related to JAK inhibition responsible for a particular or more pronounced effect on pain. Besides…”
Get full text

Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA) by Doumen, Michaël, De Meyst, Elias, Lefevre, Cedric, Pazmino, Sofia, Joly, Johan, Bertrand, Delphine, Devinck, Mieke, Westhovens, René, Verschueren, Patrick

“…Abstract Background Rheumatoid arthritis (RA) considerably impacts patients’ lives. Patients’ confidence in their ability to manage this impact, or…”
Get full text

Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis by Yu, Karen, Dillemans, Luna, Gouwy, Mieke, Bessa, Helena, Metzemaekers, Mieke, Martens, Erik, Matthys, Patrick, Bossuyt, Xavier, Verschueren, Patrick, Wouters, Carine, De Somer, Lien, Proost, Paul

“…Peptidylarginine deiminases (PADs) mediate citrullination, an irreversible posttranslational modification that converts arginine to citrulline residues in…”
Get full text

CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts by Pathak, Janak L, Bakker, Astrid D, Verschueren, Patrick, Lems, Willem F, Luyten, Frank P, Klein-Nulend, Jenneke, Bravenboer, Nathalie

“…Generalized osteoporosis is common in patients with inflammatory diseases, possibly because of circulating inflammatory factors that affect osteoblast and…”
Get full text

Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay by Op De Beeck, Katrijn, Vermeersch, Pieter, Verschueren, Patrick, Westhovens, René, Mariën, Godelieve, Blockmans, Daniel, Bossuyt, Xavier

“…Abstract Testing for antinuclear antibodies is useful for the diagnosis of systemic rheumatic diseases. Solid phase assays are increasingly replacing indirect…”
Get full text

Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity by Dillemans, Luna, Yu, Karen, De Zutter, Alexandra, Noppen, Sam, Gouwy, Mieke, Berghmans, Nele, Verhallen, Lisa, De Bondt, Mirre, Vanbrabant, Lotte, Brusselmans, Stef, Martens, Erik, Schols, Dominique, Verschueren, Patrick, Rosenkilde, Mette M, Marques, Pedro Elias, Struyf, Sofie, Proost, Paul

“…Interferon-γ-inducible protein of 10 kDa (IP-10/CXCL10) is a dual-function CXC chemokine that coordinates chemotaxis of activated T cells and natural killer…”
Get full text